Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion type Assertion NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_head.
- NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion description "[Irinotecan should be used cautiously in dialysis patients with metastatic colorectal cancer and screening for UGT1A polymorphisms may help in identifying patients with lower SN-38 glucuronidation rates and greater susceptibility to irinotecan-induced toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_provenance.
- NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion evidence source_evidence_literature NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_provenance.
- NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion SIO_000772 21617725 NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_provenance.
- NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion wasDerivedFrom befree-20150227 NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_provenance.
- NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_assertion wasGeneratedBy ECO_0000203 NP766354.RAe8hVUHjhlY7bFRT9Q8ec3u3kX9yQhXWis-v68vm1m3o130_provenance.